Franz X. Schaub

1.5k total citations
23 papers, 688 citations indexed

About

Franz X. Schaub is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Franz X. Schaub has authored 23 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Franz X. Schaub's work include Cancer Genomics and Diagnostics (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and RNA modifications and cancer (4 papers). Franz X. Schaub is often cited by papers focused on Cancer Genomics and Diagnostics (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and RNA modifications and cancer (4 papers). Franz X. Schaub collaborates with scholars based in United States, Switzerland and Germany. Franz X. Schaub's co-authors include John L. Cleveland, Radek C. Skoda, André Tichelli, Renate Looser, Hui Hao-Shen, Thomas Lehmann, Sai Li, Joanne R. Doherty, Mohammad Fallahi and Antonio L. Amelio and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Franz X. Schaub

21 papers receiving 680 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Franz X. Schaub 498 218 195 129 87 23 688
Amitava Sengupta 460 0.9× 103 0.5× 237 1.2× 114 0.9× 76 0.9× 38 718
YinWei Ho 608 1.2× 263 1.2× 530 2.7× 262 2.0× 168 1.9× 14 1.1k
Brooke Snetsinger 287 0.6× 141 0.6× 242 1.2× 104 0.8× 92 1.1× 18 664
Maurizio Affer 571 1.1× 92 0.4× 401 2.1× 176 1.4× 79 0.9× 22 843
AD D'Andrea 263 0.5× 135 0.6× 336 1.7× 182 1.4× 78 0.9× 20 667
Baskar Ramdas 367 0.7× 182 0.8× 337 1.7× 92 0.7× 112 1.3× 33 723
Alice Cani 394 0.8× 105 0.5× 120 0.6× 126 1.0× 121 1.4× 26 645
Sagi Abelson 520 1.0× 82 0.4× 290 1.5× 204 1.6× 213 2.4× 27 866
Ernesto Díaz-Flores 558 1.1× 119 0.5× 305 1.6× 198 1.5× 84 1.0× 29 859
Petranel T. Ferrão 336 0.7× 101 0.5× 151 0.8× 206 1.6× 51 0.6× 8 629

Countries citing papers authored by Franz X. Schaub

Since Specialization
Citations

This map shows the geographic impact of Franz X. Schaub's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franz X. Schaub with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franz X. Schaub more than expected).

Fields of papers citing papers by Franz X. Schaub

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franz X. Schaub. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franz X. Schaub. The network helps show where Franz X. Schaub may publish in the future.

Co-authorship network of co-authors of Franz X. Schaub

This figure shows the co-authorship network connecting the top 25 collaborators of Franz X. Schaub. A scholar is included among the top collaborators of Franz X. Schaub based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franz X. Schaub. Franz X. Schaub is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fernandez, Mario R., Franz X. Schaub, Chunying Yang, et al.. (2022). Disrupting the MYC-TFEB Circuit Impairs Amino Acid Homeostasis and Provokes Metabolic Anergy. Cancer Research. 82(7). 1234–1250. 9 indexed citations
2.
Schaub, Franz X., et al.. (2020). Tumor-Derived Organoid Culture For Functional Personalized Oncology In Cholangiocarcinoma. HPB. 22. S26–S27. 1 indexed citations
3.
Lui, Goldie Y.L., Reid Shaw, Franz X. Schaub, et al.. (2020). BET, SRC, and BCL2 family inhibitors are synergistic drug combinations with PARP inhibitors in ovarian cancer. EBioMedicine. 60. 102988–102988. 26 indexed citations
4.
Schaub, Franz X., Michael Churchill, Rachele Rosati, et al.. (2020). Abstract 818: Organoid based functional test to predict personalized treatment in cholangiocarcinoma. Cancer Research. 80(16_Supplement). 818–818. 2 indexed citations
5.
Churchill, Michael, Franz X. Schaub, Rachele Rosati, et al.. (2020). Predictive value of a CLIA-approved organoid based drug sensitivity test.. Journal of Clinical Oncology. 38(15_suppl). 3630–3630. 4 indexed citations
6.
Li, Weimin, John L. Cleveland, Md. Shamim Reza, et al.. (2020). Fluorophore-NanoLuc BRET Reporters Enable Sensitive In Vivo Optical Imaging and Flow Cytometry for Monitoring Tumorigenesis. UNC Libraries. 2 indexed citations
7.
Zarrinpar, Ali, et al.. (2019). Functional personalized oncology to determine drug sensitivity in cholangiocarcinoma.. Journal of Clinical Oncology. 37(15_suppl). e15672–e15672.
8.
Xu, Chang, Olga Nikolova, Ryan Basom, et al.. (2018). Functional Precision Medicine Identifies Novel Druggable Targets and Therapeutic Options in Head and Neck Cancer. Clinical Cancer Research. 24(12). 2828–2843. 19 indexed citations
9.
Rosati, Rachele, Michael Churchill, Reid Shaw, et al.. (2018). Abstract 1619: Personalized medicine: A CLIA-certified high-throughput drug screening platform for ovarian cancer. Cancer Research. 78(13_Supplement). 1619–1619. 3 indexed citations
10.
Schaub, Franz X., Md. Shamim Reza, Colin A. Flaveny, et al.. (2015). Fluorophore-NanoLuc BRET Reporters Enable Sensitive In Vivo Optical Imaging and Flow Cytometry for Monitoring Tumorigenesis. Cancer Research. 75(23). 5023–5033. 92 indexed citations
11.
Schaub, Franz X., Weimin Li, Mohammad Fallahi, et al.. (2015). Myc-Directed Suppression of Autophagy Provides Therapeutic Vulnerabilities Targeting Amino Acid Homeostasis. Blood. 126(23). 2450–2450. 2 indexed citations
12.
Ghalei, Homa, Franz X. Schaub, Joanne R. Doherty, et al.. (2015). Hrr25/CK1δ-directed release of Ltv1 from pre-40S ribosomes is necessary for ribosome assembly and cell growth. The Journal of Cell Biology. 208(6). 745–759. 61 indexed citations
13.
Hoellein, Alexander, Mohammad Fallahi, Stephanie Schoeffmann, et al.. (2014). Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma. Blood. 124(13). 2081–2090. 73 indexed citations
14.
Amelio, Antonio L., Mohammad Fallahi, Franz X. Schaub, et al.. (2014). CRTC1/MAML2 gain-of-function interactions with MYC create a gene signature predictive of cancers with CREB–MYC involvement. Proceedings of the National Academy of Sciences. 111(32). E3260–8. 27 indexed citations
15.
Rounbehler, Robert J., Mohammad Fallahi, Chunying Yang, et al.. (2012). Tristetraprolin Impairs Myc-Induced Lymphoma and Abolishes the Malignant State. Cell. 150(3). 563–574. 91 indexed citations
16.
Königsrainer, Alfred, Randolph Schaffer, Franz X. Schaub, et al.. (2012). Organ donation: when should we consider intestinal donation. Transplant International. 25(12). 1229–1240. 15 indexed citations
17.
Schaub, Franz X., Roland Jäger, Renate Looser, et al.. (2008). Clonal analysis of deletions on chromosome 20q and JAK2-V617F in MPD suggests that del20q acts independently and is not one of the predisposing mutations for JAK2-V617F. Blood. 113(9). 2022–2027. 50 indexed citations
18.
Schmitt‐Graeff, Annette, Swee‐Sen Teo, Manfred Olschewski, et al.. (2007). JAK2V617F mutation status identifies subtypes of refractory anemia with ringed sideroblasts associated with marked thrombocytosis. Haematologica. 93(1). 34–40. 74 indexed citations
19.
Schaub, Franz X., Ralph Tiedt, Sylvie Hermouet, et al.. (2007). Characterization of del20q in Peripheral Blood of MPD Patients Using Copy Number Analysis and High Resolution Oligonucleotide CGH Array. Blood. 110(11). 1530–1530. 2 indexed citations
20.
Schaub, Franz X., et al.. (1953). [Side-effects and consequences of chronic phenacetin abuse].. PubMed. 83(27). 626–9. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amitava Sengupta Breakdown of academic impact, for papers by YinWei Ho Breakdown of academic impact, for papers by Brooke Snetsinger Breakdown of academic impact, for papers by Maurizio Affer Breakdown of academic impact, for papers by AD D'Andrea Breakdown of academic impact, for papers by Baskar Ramdas Breakdown of academic impact, for papers by Alice Cani Breakdown of academic impact, for papers by Sagi Abelson Breakdown of academic impact, for papers by Ernesto Díaz-Flores Breakdown of academic impact, for papers by Petranel T. Ferrão
Rankless by CCL
2026